NEUMORA THERAPEUTICS, INC. (NMRA) Operating cash flow 2022–2025
NEUMORA THERAPEUTICS, INC. (NMRA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$206.4MFY2025 · since FY2022: -$114.9M → -$206.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$206.4M | -12.8% |
| FY2024 | -$182.9M | -12.0% |
| FY2023 | -$163.3M | -42.1% |
| FY2022 | -$114.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NMRA financial trends
NMRA RevenueNMRA Net incomeNMRA Net marginNMRA Gross profitNMRA Gross marginNMRA Operating incomeNMRA Operating marginNMRA Free cash flowNMRA Capital expendituresNMRA Return on equityNMRA Stock buybacksNMRA Dividends paidNMRA Total assetsNMRA Total liabilitiesNMRA Shareholders’ equityNMRA overview →